Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing.

about

Identification of Prognostic and Susceptibility Markers in Chronic Myeloid Leukemia Using Next Generation Sequencing.

Item

http://www.wikidata.org/entity/Q55479692

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Identification of Prognostic a ...... ng Next Generation Sequencing.

@en

Identification of Prognostic a ...... ng Next Generation Sequencing.

@nl

type

Item

label

Identification of Prognostic a ...... ng Next Generation Sequencing.

@en

Identification of Prognostic a ...... ng Next Generation Sequencing.

@nl

prefLabel

Identification of Prognostic a ...... ng Next Generation Sequencing.

@en

Identification of Prognostic a ...... ng Next Generation Sequencing.

@nl

P1476

Identification of Prognostic a ...... ng Next Generation Sequencing.

@en

P2093

Abhishek Vats

http://www.w3.org/2001/XMLSchema#string

Mayank Jauhri

http://www.w3.org/2001/XMLSchema#string

Neeta Raj Sharma

http://www.w3.org/2001/XMLSchema#string

Sachin Minhas

http://www.w3.org/2001/XMLSchema#string

Satish Sankaran

http://www.w3.org/2001/XMLSchema#string

Shyam Aggarwal

http://www.w3.org/2001/XMLSchema#string

Vibha Taneja

http://www.w3.org/2001/XMLSchema#string

Yogender Shokeen

http://www.w3.org/2001/XMLSchema#string

P2860

A haplotype map of the human genome

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV.

Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.

Mechanisms of primary and secondary resistance to imatinib in chronic myeloid leukemia.

Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.

An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.

Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis.

Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes.

P304

135-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4314/EJHS.V28I2.5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29983511

http://www.w3.org/2001/XMLSchema#string

P921

chronic myeloid leukemia

P932

6016334

http://www.w3.org/2001/XMLSchema#string